90.60
-1.33(-1.45%)
Currency In USD
| Previous Close | 91.93 |
| Open | 92.25 |
| Day High | 94 |
| Day Low | 90.45 |
| 52-Week High | 99.5 |
| 52-Week Low | 52.5 |
| Volume | 306,958 |
| Average Volume | 475,878 |
| Market Cap | 1.97B |
| PE | -131.3 |
| EPS | -0.69 |
| Moving Average 50 Days | 93.49 |
| Moving Average 200 Days | 72.29 |
| Change | -1.33 |
If you invested $1000 in ANI Pharmaceuticals, Inc. (ANIP) 10 years ago, it would be worth $2,023.68 as of November 02, 2025 at a share price of $90.6. Whereas If you bought $1000 worth of ANI Pharmaceuticals, Inc. (ANIP) shares 5 years ago, it would be worth $3,294.55 as of November 02, 2025 at a share price of $90.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET
GlobeNewswire Inc.
Oct 24, 2025 10:50 AM GMT
PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its third quarter 2025 financial results on Friday, November 7, 2025, prior to the market
ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting
GlobeNewswire Inc.
Oct 16, 2025 10:50 AM GMT
Presentation at AAO 2025 part of ongoing NEW DAY data dissemination at medical meetingsPRINCETON, N.J., Oct. 16, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that results from the NEW DA
ANI Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
Aug 25, 2025 8:30 PM GMT
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadershi